332 search results for “cancer planning” in the Staff website
-
Data-driven approaches to study breast cancer metabolism
PhD defence
-
Annual Plan
An annual plan ensures that Planning & Control is embedded in the organisation. The plan states who provides what and when. This means that the right information is available at the right time, allowing for the proper financial management of the University.
-
700,000 euros for the fight against aggressive breast cancer
To inhibit proteins that contribute to the growth of aggressive cancer cells, that’s the plan of Professor Bob van de Water and his team. They will receive over 700,000 euros from the KWF Dutch Cancer Society for their research. Researcher Maaike Vreeswijk and pathologist Danielle Cohen are affiliated…
-
Sebastian Pomplun joins Oncode Institute to accelerate breakthroughs in cancer research
Sebastian Pomplun manages to reach proteins with drugs even where this was thought impossible. That is why he and his research group have been allowed to join Oncode Institute. With nine others, he had been selected from 72 applicants to contribute to Oncode Institute's mission: to accelerate breakthroughs…
-
Strategic plan
In our new strategic plan (Innovating and Connecting – 2022-2027) we focus on stronger connections: between disciplines, with society and within our university community.
-
Niek ZamanFaculteit der Rechtsgeleerdheid
d.f.m.m.zaman@law.leidenuniv.nl | 071 5272727
- Vision and Strategy Plan
-
Vision & strategic plan
The university has developed a vision on education, Learning@LeidenUniversity. This vision together with the strategic plans from both the university and the faculty provide direction for our education.
-
Planning an event
If you’re planning to organise an event within the university, the information on this page will help you get started.
-
Planning an event
If you’re planning to organise an event within the university, the information on this page will help you get started.
-
Promising new technique to treat cancer receives NWO grant
Biological chemist Nathaniel Martin and his team received an NWO grant to examine how blocking a specific enzyme in our body, NNMT, could be helpful in the treatment of some cancers. Trials with mice have been promising, and together with the Netherlands Cancer Institute, Martin wants to take the next…
-
Is a cancer pill a matter of time?
A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves are contributing to new cancer treatments.
-
Data Management Plan course for PhD's
Didactics, Career development
-
Step-by-step plan towards more impact
An important question being asked, both in the academic world and in society, concerns the impact of our research and education. By providing a well-supported answer, we not only create a strong position for our research, we also increase our chances of success in applying for research grants and retaining…
-
Step-by-step plan towards more impact
An important question being asked, both in the academic world and in society, concerns the impact of our research and education. By providing a well-supported answer, we not only create a strong position for our research, we also increase our chances of success in applying for research grants and retaining…
-
Career planning for PhD Candidates and Postdocs
Career development, Transferable skills
-
Danka SaijaFaculteit der Rechtsgeleerdheid
d.j.saija@law.leidenuniv.nl | 071 5272727
-
3D-printed mini-tumours: a leap forward in improving cancer immunotherapy
Leiden researchers have developed a groundbreaking model to advance cancer immunotherapy. Using a 3D printer, they create mini-tumors within an environment that closely mimics human tissue. They have also developed a method to monitor real-time interactions of these mini-tumours with immune cells during…
-
Chemotherapy without side effects: Matthijs Hakkennes helps find the needle in the haystack faster
Chemotherapy, but without hair loss or extreme fatigue. It may be possible if the toxic drug only becomes active where it is ‘switched on’ by light. Matthijs Hakkennes has helped bring that idea closer to reality and obtained his PhD cum laude. ‘I received many thank-you emails from China and Bangla…
-
Anouk GoemansFaculty of Social and Behavioural Sciences
a.goemans@law.leidenuniv.nl | 071 5272727
-
Workshop: How to write a Data Management Plan (DMP)
Workshop
-
Workshop: How to write a Data Management Plan (DMP)
Workshop
-
Helping cancer patients with treatment choices
Researchers at the Leiden Institute of Advanced Computer Science (LIACS) are collaborating on the development of a conversation tool for patients with breast, prostate and skin cancer. The aim is to create a conversation tool that can support cancer patients in their care and help them make decisions.…
-
Oncode Accelerator launched: patients at the centre of innovative cancer drug development
Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop cancer treatments, thus ensuring the patient is at the heart of the process.
-
Better understanding of cancer drugs – Leiden spin-off Omivera receives seed investment
How do you know if a drug will actually work? The Leiden-based spin-off Omivera is developing a new technology that could provide clearer answers. The young company received a seed investment from the investment fund UNIIQ to support its development.
-
Hanneke LeegwaterFaculty of Science
h.leegwater@lacdr.leidenuniv.nl | 071 5272727
-
How Leiden University is taking action against cancer
One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden University is conducting various studies aimed at preventing and controlling cancer. Below are just a few examples.
-
Tanya TsuiFaculty of Science
t.p.y.tsui@cml.leidenuniv.nl | 071 5272727
-
Ewa Snaar-JagalskaFaculty of Science
b.e.snaar-jagalska@biology.leidenuniv.nl | 071 5272727
-
Leila Akkari appointed Special Professor of Cancer–immune interactions
Leila Akkari was appointed Special Professor of Cancer-immune interactions at the Leiden Institute of Chemistry (LIC) on 15 December. Akkari is a researcher at the Netherlands Cancer Institute (NKI), where she studies the relationship between cancer cells and the immune system, with a particular focus…
-
New potential cancer drugs and where to find them
Cancer research generates massive amounts of data, but traditional tools often fail to fully harness their potential. How can we unlock this data to provide better treatments for cancer patients? PhD candidate Marina Gorostiola González explored this by using advanced data analysis techniques to guide…
-
€10.6 million for innovative toolboxes to tackle brain cancer
Researchers at the Universities of Amsterdam (Uva) and Leiden together with the Netherlands Cancer Institute and Oncode Institute have received a €10,6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma. This is a deadly primary brain tumour for which no curing…
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
KiKa grant for mathematician: how statistics helps fight bone cancer
Using mathematics to help children with bone cancer. It sounds a little strange, but for statistician Marta Fiocco, it's just her job. She gets a substantial grant from KiKa for it. With that money, she is going to study the effect of chemotherapy adjustments.
-
Cecilia BergonziniFaculty of Science
c.bergonzini@lacdr.leidenuniv.nl | 071 5274496
-
Synthetic Miniproteins Enter the Fight Against MYC-Driven Cancers
The transcription factor MYC is a master regulator implicated in the majority of human cancers. Despite its central role, MYC has long been considered "undruggable" by small molecules, lacking binding pockets and featuring disordered regions. While larger biomolecules could potentially disrupt MYC function,…
-
Special nanoparticles for cancer therapy! Will you help?
Developing a better treatment for patients with head and neck cancer, that is what Binanox, The 2022 iGEM Leiden team, want to achieve. They hope to raise at least 10,000 euros for this cause. Support their crowdfunding campaign today.
-
Judith BovéeFaculty of Medicine
j.v.m.g.bovee@lumc.nl | 071 5269111
-
Bianca de KroonFaculteit der Rechtsgeleerdheid
b.b.a.de.kroon@law.leidenuniv.nl | 071 5272727
-
Frans SonneveldtFaculteit der Rechtsgeleerdheid
f.sonneveldt@law.leidenuniv.nl | 071 5272727
-
Marleen Waaijer-Linders -
Energy as a weak spot: a new approach to tackle aggressive breast cancer?
Could we stop cancer cells by cutting off their energy supply? That’s what Dione Blok, a bachelor’s student in Bio-Pharmaceutical Sciences, aimed to find out during her thesis research. She investigated a compound that affects the tumour cells’ energy metabolism. ‘Hopefully, these insights will provide…
-
Leiden joins EU effort to unite Europe’s cancer research networks
The more data from cancer research we pool, the better we can search for new treatments. But how can we keep patient data safe when sharing it? Leiden researchers will tackle this challenge in a major European project.
-
Unlocking the secrets of DNA repair: Sarah’s curiosity might lead to new cancer treatments
How do cells repair their damaged DNA—and what happens when that process is hindered and cancer arises? Sarah Moser has taken a closer look during her PhD, uncovering surprising insights that could help improve future cancer treatments.
-
Catrin LutzFaculty of Science
c.lutz@lacdr.leidenuniv.nl | 071 5276270
-
Chenlin FengFaculty of Science
c.l.feng@lacdr.leidenuniv.nl | 071 5272727
-
Rietveld Award for innovative research on blood donation and colorectal cancer
One used 3D cell models to study colorectal cancer, while the other used machine learning for more efficient blood donation. For these achievements, Marieke Vinkenoog and Simon Christian Hansmann were awarded the Krijn Rietveld Memorial Innovation Award on Tuesday 2 September.
-
receives ERC Proof of Concept grant for MYSTIC, to advance an innovative cancer treatment idea
Sebastian Pomplun from the Leiden Academic Centre for Drug Research has recently received an ERC Proof of Concept grant for his ambitious MYSTIC project. This initiative is set to transform cancer treatment by advancing the development of HeloMYC, a pioneering therapeutic candidate designed to target…
-
From forming embryo to cancer metastasis: the significance of collective cell movement
Luca Giomi has the first results of his ERC consolidator grant. He discovered that epithelial cells move collectively but in different ways, depending on the scale you look at. It is hexatic at small scales, and becomes nematic at larger scales: it is a multiscale order. This collective movement of…
-
Physics in the picture: cancer cells as an explosion of fireworks
When you think of physics, do you think only of complicated formulas? You’re not the only one. Therefore, every year, the Leiden Insitute of Physics organises the LION Image Award to show another side of physics: beautiful images about intriguing science. The winner of the 2022 photo competition captured…